Skip to main content
. 2015 Feb;12(2):116–146. doi: 10.2174/1567205012666150204121719

Table 2.

Body burden (blood, urine, total body levels), minimum risk levels, and exposure limits for environmental contaminates in healthy individuals.

Environmental Contaminants Name Levels in Blood, Urine (Mean/ Range) Total Body Level Minimal Risk Levels (MRLs) Exposure Limits* Reference
TOXIC METALS
Aluminum Blood 1-3 µg/L
Urine mean value 23.7 µg/L
For 70 kg adult 30–50 mg/ kg body weight 1 mg aluminum/kg/day
for chronic oral
exposure (≥365 days)
NIOSH REL TWA 10 mg/m3 [205, 207]
Arsenic ≤ 1 ppm in nails
≤ 1 ppm in hair
Blood < 1 μg/L in
Urine 0.0-35 µg/L
Toxicity of arsenic depends upon exposure 0.005 mg As/kg/day for acute oral exposure (≤14 days) to inorganic arsenic;
0.0003 mg As/kg/day for chronic oral exposure (≥1 year) to inorganic arsenic
NIOSH REL TWA 0.002 mg/m3 [23, 207]
Cadmium Blood level 0.315 µg/L
Urine level 0.193 µg/g creatinine (0.185 µg/L)
For 70 kg adult, 10-50 mg/ kg body weight 1 X 10-5 mg Cd/m3 has been derived for chronic inhalation exposure to cadmium (≥1 year).
3 X 10-5 mg Cd/m3 has been derived for acute- inhalation exposure to cadmium (≤14 days)
NIOSH REL TWA 0.002 mg/m3 [207, 208]
Cobalt Blood levels 0.05–0.19 µg/dL
Urine levels 0.04–2 µg/dL
Air levels at unpolluted sites <1–2 ng/m3
For 70 kg adult, 1.1–1.5 mg/ kg body weight, with 0.11 mg in the liver. 0.0001 mg cobalt/m3 for chronic inhalation exposure (>365 days) to cobalt
0.01 mg Co/kg-day for intermediate oral exposure (<365 days)
NIOSH REL TWA 0.05 mg/m3 [48, 207]
Copper Serum copper 151.6 µg/100 mL
Urine 18 µg/ g dry weight
For 70 kg adult, 50–70 mg/ kg body weight 0.01 mg/kg/day for acute (1–14 days) and intermediate oral exposure (15– 365 days) oral exposure to copper NIOSH REL TWA 0.1 mg/m3 [85, 207]
Iron Serum ferritin 128.58±13.85 µg% 4.333 mg/kg body weight for women - NIOSH REL TWA 1 mg/m3 [209, 210]
Lead Blood 1.5 μg/dL for adults 20–59 years
Urine 0.677 μg/L for ≥ 6 years of age
For 70 kg adult, 22.0-441.8 mg No MRLs derived because more sensitive effects have not been established in humans NIOSH REL TWA (8 hour) 0.050 mg/m3 [207, 211]
Manganese Serum (≥16 years) 0.6-2.3 ng/mL
Urine (aged 6–88 years) 1.19 µg/L
For 70 kg adult, 10 to 20 mg No MRLs derived
interim guidance value 0.16 mg manganese/kg/day
NIOSH REL TWA 1 mg/m3 [207, 212]
Mercury Blood – below 5 ng/mL
Urine – below 20 ng/mL
In exposed individuals blood 9.8 ± 2.2 µg/L Chronic inhalation 0.2 µg/m3 for metallic mercury;
oral acute 0.007 mg/kg/day and intermediate 0.002 mg/kg/day duration exposures to inorganic mercury
NIOSH REL TWA (vapour) 0.05 mg/m3 [207, 213, 214]
  Selenium Serum 0.125 mg/L 15 mg in Americans No MRL was derived for acute exposure
0.005 mg Se/kg/day was
derived for chronic oral exposure (≥1 year)
low adverse effect level of dietary selenium 1,540–1,600 mg daily
NIOSH REL TWA 0.2 mg/m3 [207, 215, 216]
Zinc Serum 1 µg/mL
Urine 0.5 mg/g creatinine
For 70 kg adult, 0.66 -2.63 g/kg body weight 0.3 mg Zn/kg/day for intermediate oral exposure (15–364 days). NIOSH REL TWA 10 mg/m3 [207, 211]
PESTICIDES and INSECTICIDES
Organochlorine pesticides (OCPs) include hexachlorocyclohexane (lindane, HCH),
aldrin, dieldrin, endosulfan,
p,p’-dichlorodiphenyl-dichloroethylene (pp’-DDE), o,p’-DDE,
p,p’-dichlorodipheny-ltrichloroethane (pp’-DDT), o,p’-DDT,
p,p’-dichlorodiphenyl-dichloroethane (p,p’-DDD) and o,p’-DDD
Serum aldrin 0.004 mg/L and dieldrin 0.002 mg/L in India;
serum HCH 0.0182 mg/L;
dieldrin 0.0161 mg/L
pp′-DDE 1.31 mg/L in unexposed New Zealand adults;
serum dieldrin (>12-year-old and older) 0.146 mg/L (whole blood) in USA adults;
urine DDT+ DDE 400 µg/L
Serum dieldrin in farmers 127±27.2 µg/g fat;
serum SHCH in farmers 4.3 ± 0.1 ng/g fat;
serum SDDT in farmers 7.6 ± 1.7 ng/g fat
0.002 mg/kg/day for acute exposure to aldrin (≤14 days);
0.00003 mg/kg/day for chronic exposure to aldrin (≥1 year);
0.0001 mg/kg/day for intermediate exposure to dieldrin (15–364 days);
0.00005 mg/kg/day for chronic exposure to dieldrin (≥1 year);
acute oral 0.0005 mg/kg/day for DDT;
intermediate 0.0005 mg/kg/day for DDT
NIOSH REL TWA Dieldrin 0.25 mg/m3 [skin];
NIOSH REL TWA HCH, 0.5 mg/m3 [skin];
NIOSH REL TWA Endosulfan 0.1 mg/m3 [skin];
DDT, 0.5 mg/m3
[207, 217, 220]
Organophosphate insecticides (OPIs) including methyl parathion, dimethyl parathion, trichlorfon (TCF), chlorpyrifos (CPF) No reference values After exposure, 0.156 mg/L serum methyl parathion 0.0007 mg/kg/day for intermediate oral exposure (15–364 days) to methyl parathion;
0.0003 mg/kg/day for chronic oral exposure (365 days or more) to methyl parathion
NIOSH REL TWA 0.05 mg/m3 [skin] for dimethyl parathion [207]
Carbamates (e.g., carbofuran) Urine 28 µg/kg (farmers) Blood carbofuran 0.4 -18 µg/mL poisoning Mild effects at 0.1 mg/kg body weight/day NIOSH REL TWA 0.1 mg/m3 [221], 223
Bipyridyles (paraquat, diquat) No reference values Serum 0.4 - 4.0 µg/mL level after paraquat poisoning Less than 20 mg paraquat ion per kg body weight NIOSH REL TWA 0.1 mg/m3 (resp) [skin] for paraquat [224]
Rotenone No reference values Toxicity or poisoning values vary 40 mg/L drinking water NIOSH REL TWA 5 mg/m3 [225]
Fipronil No reference values Toxicity or poisoning values vary No MRL Fipronil NOAEL 0.025 mg/kg bw per day;
human chronic RfD 300 ng/L/day
[226]
Pyrethroids (permethrin deltamethrin) No reference values Not evaluated 0.3 mg/kg/day acute oral exposure to permethrin (≤14 days);
0.2 mg/kg/day intermediate oral exposure to permethrin (15–364 days);
no chronic-duration oral MRLs
EPA exposure limits 0.005-0.05 mg/kg/day [207]
Neonicotinoids (acetamiprid, imidacloprid) No reference values Due to poisoning
plasma acetamiprid 10.58 ng/L;
plasma acetamiprid < 44.6 ng/L;
plasma imidacloprid 2.3-59.8 mg/L
Acute dietary acetamiprid exposure 0.039 mg/kg;
acetamiprid 600 mg/L (children 1-6 years)
Acetamiprid NOAEL 10 mg/kg; imidacloprid acute 14 mg/kg/day; RfD 0.057 mg/kg/day [227, 228]
OTHER INDUSTRIAL and COMMERCIAL CHEMICALS
Alkylphenol-polyethoxylates
(APEOs) including Octylphenol (OP)
95th percentile 2.2 (1.6–3.2) µg/L 4-tert-Octylphenol exposed blood serum1.4 ng/g (wet weight) No MRL [229]
Brominated flame retardants (BFRs) including hexabromocyclo-dodecane (HBCD),
tetrabromobisphenol-A (TBBPA), decabromodiphenyl ether (DBDE), polybrominated diphenyl ethers (PBDEs)
Serum congeners BDE-47[geometric mean 20.5 ng/g lipid]; BDE-153 [5.7 ng/g lipid]; BDE-99 [5.0 ng/g lipid; BDE-100 [3.9 ng/g lipid]; BB-153 [2.3 ng/g lipid]; and BDE-28 [1.2 ng/g lipid]. Breast milk PBDEs 4-419 ng/g lipid
PBDE group (BDE-47, 99, 100, 153, 154) 330-2500 ng/kg fat
0.006 mg/m3 for intermediate inhalation exposure (15–364 days) to lower brominated BDEs;
10 mg/kg/day has derived for intermediate oral exposure (15–364 days) to DBDE
HBCD NOAEL 14.8 mg/kg-day;
TBBPA NOAEL inhalation > 18mg/L; NOAEL oral >100 mg/kg to >2500 mg/kg;
pentaPBDE NOAEL 1mg/kg/d
[207, 236, 230]
Dioxins (e.g.. 2,3,7,8-Tetrachloro-dibenzo-p-dioxin (TCDD)), Polychlorinated biphenyls (PCBs), polychlorinated dibenzofurans (PCDFs), polychlorinated hydrocarbons (PAHs e.g.. naphthalene) Serum TCDD 2.34 ng/L ( 0.58 – 5.5 )
Serum PCBs 6.2 mg/L
TCDD body burden 20 ng/L;
in individuals 13 years after exposure: serum PCDFs 1,030 ng/kg lipid;
serum PCBs 2,220 ng/kg
lipid
0.03 µg/kg/day intermediate oral exposure (15–364 days) to PCBs;
0.02 µg/kg/day chronic oral exposure (365 days or more) to PCBs;
No acute, or chronic oral MRLs were derived for PAHs;
0.6 mg/kg/day intermediate oral exposure (15-364 days) to acenaphthene
NIOSH REL TWA for PCB 0.001 mg/m3 [207, 237, 238]
Bisphenol A (BPA) Serum BPA unexposed 0.276 mg/L
Urine BPA unexposed 2000 ug/L
Serum BPA median 3.198 mg/L 0.02 µg/kg bw/day minimal health risk to infants and children NOAEL 5 mg/kg body weight/day [204, 219, 239, 240]
Phthalates (monoethyl phthalate (MEP), mono-2-ethylhexyl phthalate (MEHP), monobutyl phthalate (MBP), and monobenzyl phthalate (MBzP), diethylhexyl phthalate (DEHP), di-n-butyl phthalate (DBP), benzylbutyl phthalate (BzBP), and diethyl phthalate (DEP) In blood; MEP (148000 ng/L), MBP (15100 ng/L), MBzP (7000 ng/L), MEHP (5400 ng/L), and MMP (4500 ng/L);
urine DEHP <3.6 µg/kg body weight/day;
total phthalates 437.9 ng/mL (8.9-47585 ng/mL)
- DEHP 0.1 mg/kg/day for intermediate oral exposure (15–364 days);
DEHP 0.06 mg/kg/day was derived for chronic-duration oral exposure (≥365 days)
DBP NOAEL125 mg/kg/d;
BzBP NOAEL159 mg/kg/d;
DEP NOAEL 750 mg/kg/d
[207, 241, 243]
ANTIMICROBIALS
Parabens (ethyl, benzyl, butyl, methyl, propyl) Urine methyl paraben: female106- 1,230 male 25.3- 727;
urine ethyl paraben: female2.0-138 male <LOD-36.4;
urine propyl paraben female 20.2-361 male 2.0-134;
butyl paraben female 0.300-31.8 male <LOD-2.70
0.03 mg/kg bw/day No MRL 0.79, 0.34, and 0.0016 mg/kg bw/day for methyl-, propyl- and butylparaben, respectively [165, 244, 247]
Triclosan Plasma TCS 11 ng/g (age 16–45 years Australians);
urine TCS 6.4 mg/L (mg/g creatinine)
urine 2.400-3790000 ng/L in USA;
blood levels males; 136760 ng/L, females 95380 ng/L in USA
Urine triclosan concentrations are highest during the third decade of life No MRL [248, 250]
Triclocarban Serum TCC 0.45 ng/mL;
urine TCC 3.85 ng/mL
1% to 5% by body weight No MRL - [159, 162]
Hexachlorophene (HCP) Blood 0.02-0.14 mg/L 0-80 µg/kg adipose tissue 6 µg/L in drinking water - [251]
AIR POLLUTANTS
Particulate matter (PM) (heavy metals and toxic elements), Ozone (O3) Sulfate particles (pg/m3) 0.7-7.4
Inhalable PM (pg/m3) 15.4- 32.7
Sulfur dioxide (ppb) 0.2-12.9
Ozone, 24-hr avg. (ppb) 16.3-34.8
Nitric acid (ppb) 0.3-2.1 (l ppb = 40.9 nmol/m3)
- Relative risk associated with a 10 µg/m3 change in PM10 PM2.5, 15.0 μg/m3/ year, 35 μg/m3/24 hours;
PM10, 150 μg/m3/24 hours;
ozone 0.075 ppm
carbon monoxide 9 ppm (10mg/m3)/8 hours;
sulfur Dioxide 75 ppb/1 hour;
lead 0.15 μg/m3/3 months;
nitrogen dioxide 53 ppb/year; 100 ppb/ hour
[173, 252, 253]
Volatile Organic Compounds (VOCs, e.g., naphthalene, toluene, xylene) Blood benzene 0.28 ± 0.34 ng/mL; blood m,p-xylene 0.98 ± 0.93 ng/mL; urine 1,3-butadiene 4.24 ± 12.16
urine benzene 0.75 ± 4.23;
urine toluene 0.11 ± 0.14;
urine ethylbenzene 0.66 ± 1.17; urine m,p-xylene 0.83 ± 1.18; urine o-xylene 1.22 ± 2.01
Benzene 0.009 ppm for acute-duration inhalation exposure (≤14 days); benzene 0.006 ppm for intermediate-duration inhalation exposure (15–364 days); benzene 0.003 ppm for chronic-duration inhalation exposure (≥1 year);
xylenes NOAEL 50 ppm;
no MRLS for butadiene;
toluene acute 1 ppm; chronic 0.08 ppm;
ethylbenzene acute 1 ppm, chronic 0.1 ppm
Benzene NIOSH REL TWA 0.1 ppm; air xylenes NIOSH REL 435 mg/m3; (total xylenes) drinking water 10 mg/L maximum contaminant level; ethylbenzene NIOSH REL TWA 100 ppm [207, 254]